Webinar on preclinical toxicology of antibiotics

13 November 2018
Time: 17:00-18:30 CET

REVIVE is an online space to connect and support the antimicrobial R&D community. REVIVE’s aims are to facilitate learning, connect people, and share knowledge. The REVIVE webinar series on antimicrobial drug discovery and R&D is brought to you by GARDP’s Antimicrobial Memory Recovery & Exploratory Programme.

 

REVIVE Webinar Series

Making safety a part of drug design

Moderator: Ursula Theuretzbacher, Center for Anti-Infective Agents, Austria

Speaker: Claire Sadler, Senior Toxicologist, ApconiX, UK

In this webinar, Claire Sadler discusses the toxicological challenges and pitfalls of antibiotic discovery programmes. Potential safety risks are the major reason for terminating a programme in early phases of antibiotic drug development. This webinar will help identifying the most common toxicology risks associated with antibiotic discovery and discuss potential mitigating strategies.

* This presentation was also part of the GARDP and CARB-X co-organized session ‘Antibiotic Bootcamps for Developers: Preclinical Toxicology’ at the ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance *

 

More information

We will host this live webinar with Claire Sadler and Ursula Theuretzbacher on 13 November, 2018, 17:00-18:30 CET (find your time zone here). Register here.

If you have questions or comments, please let us know. Do so by using the ‘question’ pane on the webinar control panel during the live webinar or send your questions beforehand or afterwards to: info.revive@dndi.org.